Erythroferrone is not required for the glucoregulatory and hematologic effects of chronic erythropoietin treatment in mice

Erythropoietin (EPO) acts on erythroid progenitor cells to promote their survival and differentiation to mature erythrocytes. Along with this canonical role, EPO is also reported to modulate energy metabolism, resulting in improved glucose tolerance and insulin sensitivity. EPO also stimulates the p...

Descripción completa

Detalles Bibliográficos
Autores principales: Coffey, Richard, Sardo, Ugo, Kautz, Léon, Gabayan, Victoria, Nemeth, Elizabeta, Ganz, Tomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6185995/
https://www.ncbi.nlm.nih.gov/pubmed/30315639
http://dx.doi.org/10.14814/phy2.13890

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6185995/
https://www.ncbi.nlm.nih.gov/pubmed/30315639
http://dx.doi.org/10.14814/phy2.13890

Ejemplares similares